oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,

Page 1 <amp-img class='cut-thumb gotoPage' alt='Page 1: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/1.jpg' width="142" height="106" layout="responsive"> Page 2 <amp-img class='cut-thumb gotoPage' alt='Page 2: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/2.jpg' width="142" height="106" layout="responsive"> Page 3 <amp-img class='cut-thumb gotoPage' alt='Page 3: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/3.jpg' width="142" height="106" layout="responsive"> Page 4 <amp-img class='cut-thumb gotoPage' alt='Page 4: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/4.jpg' width="142" height="106" layout="responsive"> Page 5 <amp-img class='cut-thumb gotoPage' alt='Page 5: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/5.jpg' width="142" height="106" layout="responsive"> Page 6 <amp-img class='cut-thumb gotoPage' alt='Page 6: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/6.jpg' width="142" height="106" layout="responsive"> Page 7 <amp-img class='cut-thumb gotoPage' alt='Page 7: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/7.jpg' width="142" height="106" layout="responsive"> Page 8 <amp-img class='cut-thumb gotoPage' alt='Page 8: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/8.jpg' width="142" height="106" layout="responsive"> Page 9 <amp-img class='cut-thumb gotoPage' alt='Page 9: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/9.jpg' width="142" height="106" layout="responsive"> Page 10 <amp-img class='cut-thumb gotoPage' alt='Page 10: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/10.jpg' width="142" height="106" layout="responsive"> Page 11 <amp-img class='cut-thumb gotoPage' alt='Page 11: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/11.jpg' width="142" height="106" layout="responsive"> Page 12 <amp-img class='cut-thumb gotoPage' alt='Page 12: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/12.jpg' width="142" height="106" layout="responsive"> Page 13 <amp-img class='cut-thumb gotoPage' alt='Page 13: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/13.jpg' width="142" height="106" layout="responsive"> Page 14 <amp-img class='cut-thumb gotoPage' alt='Page 14: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/14.jpg' width="142" height="106" layout="responsive"> Page 15 <amp-img class='cut-thumb gotoPage' alt='Page 15: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/15.jpg' width="142" height="106" layout="responsive"> Page 16 <amp-img class='cut-thumb gotoPage' alt='Page 16: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/16.jpg' width="142" height="106" layout="responsive"> Page 17 <amp-img class='cut-thumb gotoPage' alt='Page 17: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/17.jpg' width="142" height="106" layout="responsive"> Page 18 <amp-img class='cut-thumb gotoPage' alt='Page 18: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/18.jpg' width="142" height="106" layout="responsive"> Page 19 <amp-img class='cut-thumb gotoPage' alt='Page 19: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/19.jpg' width="142" height="106" layout="responsive"> Page 20 <amp-img class='cut-thumb gotoPage' alt='Page 20: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/20.jpg' width="142" height="106" layout="responsive"> Page 21 <amp-img class='cut-thumb gotoPage' alt='Page 21: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/21.jpg' width="142" height="106" layout="responsive"> Page 22 <amp-img class='cut-thumb gotoPage' alt='Page 22: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/22.jpg' width="142" height="106" layout="responsive"> Page 23 <amp-img class='cut-thumb gotoPage' alt='Page 23: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/23.jpg' width="142" height="106" layout="responsive"> Page 24 <amp-img class='cut-thumb gotoPage' alt='Page 24: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/24.jpg' width="142" height="106" layout="responsive"> Page 25 <amp-img class='cut-thumb gotoPage' alt='Page 25: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/25.jpg' width="142" height="106" layout="responsive"> Page 26 <amp-img class='cut-thumb gotoPage' alt='Page 26: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/26.jpg' width="142" height="106" layout="responsive"> Page 27 <amp-img class='cut-thumb gotoPage' alt='Page 27: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/27.jpg' width="142" height="106" layout="responsive"> Page 28 <amp-img class='cut-thumb gotoPage' alt='Page 28: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/28.jpg' width="142" height="106" layout="responsive"> Page 29 <amp-img class='cut-thumb gotoPage' alt='Page 29: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/29.jpg' width="142" height="106" layout="responsive"> Page 30 <amp-img class='cut-thumb gotoPage' alt='Page 30: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/30.jpg' width="142" height="106" layout="responsive"> Page 31 <amp-img class='cut-thumb gotoPage' alt='Page 31: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/31.jpg' width="142" height="106" layout="responsive"> Page 32 <amp-img class='cut-thumb gotoPage' alt='Page 32: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/32.jpg' width="142" height="106" layout="responsive"> Page 33 <amp-img class='cut-thumb gotoPage' alt='Page 33: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/33.jpg' width="142" height="106" layout="responsive"> Page 34 <amp-img class='cut-thumb gotoPage' alt='Page 34: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/34.jpg' width="142" height="106" layout="responsive"> Page 35 <amp-img class='cut-thumb gotoPage' alt='Page 35: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/35.jpg' width="142" height="106" layout="responsive"> Page 36 <amp-img class='cut-thumb gotoPage' alt='Page 36: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/36.jpg' width="142" height="106" layout="responsive"> Page 37 <amp-img class='cut-thumb gotoPage' alt='Page 37: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/37.jpg' width="142" height="106" layout="responsive"> Page 38 <amp-img class='cut-thumb gotoPage' alt='Page 38: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/38.jpg' width="142" height="106" layout="responsive"> Page 39 <amp-img class='cut-thumb gotoPage' alt='Page 39: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/39.jpg' width="142" height="106" layout="responsive"> Page 40 <amp-img class='cut-thumb gotoPage' alt='Page 40: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/40.jpg' width="142" height="106" layout="responsive"> Page 41 <amp-img class='cut-thumb gotoPage' alt='Page 41: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/41.jpg' width="142" height="106" layout="responsive"> Page 42 <amp-img class='cut-thumb gotoPage' alt='Page 42: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/42.jpg' width="142" height="106" layout="responsive"> Page 43 <amp-img class='cut-thumb gotoPage' alt='Page 43: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/43.jpg' width="142" height="106" layout="responsive"> Page 44 <amp-img class='cut-thumb gotoPage' alt='Page 44: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/44.jpg' width="142" height="106" layout="responsive"> Page 45 <amp-img class='cut-thumb gotoPage' alt='Page 45: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/45.jpg' width="142" height="106" layout="responsive"> Page 46 <amp-img class='cut-thumb gotoPage' alt='Page 46: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/46.jpg' width="142" height="106" layout="responsive"> Page 47 <amp-img class='cut-thumb gotoPage' alt='Page 47: oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,' src='https://reader035.cupdf.com/reader035/viewer/2022070800/5f024d977e708231d403990b/html5/thumbnails/47.jpg' width="142" height="106" layout="responsive">

oncologypro.esmo.org...1137 patients with metastatic colorectal cancer Overall survival among patients with KRAS wild-type colorectal cancer (primary cohort) 100 Adjusted HR (95% CD,

Documents

Advances in the Treatment of Colorectal Cancer · Advances....

Pattern of Comorbidities among Colorectal Cancer Patients in...

of metastatic patterns of colorectal cancer among patients.....

Dataset #6 normalized WP-031 · plasma samples of patients....

2015 ASCO In Review - Updates for Colorectal Cancer Patients

COLORECTAL CANCER RESEARCH & PRACTICE UPDATES · 2020. 5......

Survey of Colorectal Cancer Screening Practices in Health...

ABCB5 Identifies a Therapy-Refractory Tumor Cell Population....

Dépistage et prévention du cancer colorectal · Les...

Parcours des patients pour le cancer colorectal v1.0...

Colorectal cancer: diagnosis and management€¦ · Stage I...

Navigating Colorectal and Pancreatic Cancer Patients in a...

COLORECTAL CANCER RESEARCH & PRACTICE UPDATES · 13/5/2020....

Management of metastatic colorectal cancer patients ... ·....

Colorectal Cancer: Guide for patients

Molecular Diagnosis for Colorectal Cancer Patients · 2008....